Baker Report for 13F filed on 2025-11-14
Baker Top 10 Stock Holdings by Value
| SYMBOL | NAME_OF_ISSUER | VALUE | SHARES | DATE | RANK | PERCENT | Price | Mkt. Cap | Float | 3 Month Percentage Change | First Traded | Months to 0$ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ONC | BeOne Medicines Ltd. | 2997837357 | 8799053 | 2025-11-14 | 1 | 21.66 | 368.36 | NaN | None | 14.63% | None | None |
| 1 | INCY | Incyte Corporation | 2607370059 | 30743663 | 2025-11-14 | 2 | 18.84 | 105.41 | 18,352,246,784.00 | 163640863 | 21.27% | 1993-11-04 09:30:00 | -286.40 |
| 2 | MDGL | Madrigal Pharmaceuticals, Inc. | 982312581 | 2141701 | 2025-11-14 | 3 | 7.10 | 514.93 | 10,838,571,008.00 | 11183785 | 39.23% | 2007-02-06 09:30:00 | 46.40 |
| 3 | INSM | Insmed Incorporated | 965368731 | 6703484 | 2025-11-14 | 4 | 6.98 | 190.96 | 40,436,649,984.00 | 192368404 | 49.42% | 2000-06-01 09:30:00 | 22.50 |
| 4 | ACAD | ACADIA Pharmaceuticals Inc. | 915415365 | 42896690 | 2025-11-14 | 5 | 6.61 | 23.64 | 4,012,992,768.00 | 116336185 | -6.67% | 2004-05-27 09:30:00 | -35.70 |
| 5 | SMMT | Summit Therapeutics Inc. | 696716643 | 33722974 | 2025-11-14 | 6 | 5.03 | 18.26 | 14,077,408,256.00 | 102546960 | -30.96% | 2015-03-05 09:30:00 | 9.30 |
| 6 | RYTM | Rhythm Pharmaceuticals, Inc. | 565996738 | 5604483 | 2025-11-14 | 7 | 4.09 | 95.89 | 6,452,041,728.00 | 55119978 | -0.61% | 2017-10-09 09:30:00 | 45.30 |
| 7 | RVMD | Revolution Medicines, Inc. | 441565172 | 9455357 | 2025-11-14 | 8 | 3.19 | 64.38 | 12,513,592,320.00 | 174277804 | 78.73% | 2020-02-13 09:30:00 | 26 |
| 8 | CELC | Celcuity Inc. | 391040125 | 7915792 | 2025-11-14 | 9 | 2.83 | 86.00 | 3,648,697,344.00 | 20969939 | 66.06% | 2017-09-20 09:30:00 | 9.40 |
| 9 | KYMR | Kymera Therapeutics, Inc. | 376470881 | 6651429 | 2025-11-14 | 10 | 2.72 | 63.63 | 4,333,129,728.00 | 47266194 | 49.26% | 2020-08-21 09:30:00 | 28.60 |
------------------------------------------------------------ ------------------------------------------------------------ Baker New Positions
| SYMBOL | NAME_OF_ISSUER | VALUE | SHARES | DATE | CUSIP | RANK | PERCENT | Price | Mkt. Cap | Float | 3 Month Percentage Change | First Traded | Months to 0$ | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ABVX | Abivax S.A. | 74355080 | 875796 | 2025-11-14 | 00370M103 | 24 | 0.54 | 100.90 | 8,187,961,856.00 | 35270718 | 43.24% | 2023-10-20 09:30:00 | 1 | New |
| 1 | Celcuity Inc. | 40905126 | 30750000 | 2025-11-14 | 15102KAA8 | 33 | 0.30 | NaN | NaN | NaN | NaN | NaN | NaN | New | |
| 2 | IONS | Ionis Pharmaceuticals, Inc. | 37079925 | 566798 | 2025-11-14 | 462222100 | 35 | 0.27 | 69.84 | 12,034,698,240.00 | 160668879 | 59.52% | 1991-05-17 09:30:00 | -54.10 | New |
| 3 | RNA | Avidity Biosciences, Inc. | 27231250 | 625000 | 2025-11-14 | 05370A108 | 43 | 0.20 | 70.84 | 10,683,663,360.00 | 144309692 | 52.44% | 2020-06-12 09:30:00 | 33.60 | New |
| 4 | VKTX | Viking Therapeutics, Inc. | 9620661 | 366083 | 2025-11-14 | 92686J106 | 64 | 0.07 | 39.00 | 4,304,423,936.00 | 110514503 | -2.57% | 2015-04-28 09:30:00 | 47.20 | New |
| 5 | PHVS | Pharvaris N.V. | 9356250 | 375000 | 2025-11-14 | N69605108 | 65 | 0.07 | 24.26 | 1,559,906,944.00 | 37106241 | 5.52% | 2021-02-05 09:30:00 | 15.50 | New |
| 6 | HRTX | Heron Therapeutics, Inc. | 5357458 | 4251951 | 2025-11-14 | 427746102 | 72 | 0.04 | 1.11 | 201,717,120.00 | 151853506 | -16.54% | 1987-08-26 09:30:00 | 6.70 | New |
| 7 | MBX | MBX Biosciences, Inc. | 4861098 | 277777 | 2025-11-14 | 55287L101 | 74 | 0.04 | 24.07 | 1,099,657,472.00 | 29288874 | 63.57% | 2024-09-13 09:30:00 | 52 | New |
| 8 | VTYX | Ventyx Biosciences, Inc. | 3181934 | 1023130 | 2025-11-14 | 92332V107 | 76 | 0.02 | 9.55 | 681,475,008.00 | 53421516 | 237.46% | 2021-10-21 09:30:00 | 31.40 | New |
| 9 | LBRX | LB Pharmaceuticals Inc. | 3158000 | 200000 | 2025-11-14 | 50180M108 | 77 | 0.02 | 14.90 | 369,619,872.00 | 14516119 | nan% | 2025-09-11 09:30:00 | Missing | New |
| 10 | GBIO | Generation Bio Co. | 1190297 | 194493 | 2025-11-14 | 37148K209 | 84 | 0.01 | 5.62 | 37,327,960.00 | 4951345 | -10.65% | 2020-06-12 09:30:00 | 3.60 | New |
| 11 | VYNE | VYNE Therapeutics Inc. | 285203 | 851353 | 2025-11-14 | 92941V308 | 87 | 0.00 | 0.37 | 12,203,009.00 | 23251756 | 5.21% | 2018-01-25 09:30:00 | 12.30 | New |
------------------------------------------------------------ ------------------------------------------------------------ Baker Increased Positions
| SYMBOL | NAME_OF_ISSUER | VALUE | SHARES | DATE | CUSIP | RANK | PERCENT | Price | Mkt. Cap | Float | 3 Month Percentage Change | First Traded | Months to 0$ | PCT_CHANGE | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | INCY | Incyte Corporation | 2607370059 | 30743663 | 2025-11-14 | 45337C102 | 2 | 18.84 | 105.41 | 18,352,246,784.00 | 163640863 | 21.27% | 1993-11-04 09:30:00 | -286.40 | 0.00% | Increased |
| 1 | MDGL | Madrigal Pharmaceuticals, Inc. | 982312581 | 2141701 | 2025-11-14 | 558868105 | 3 | 7.10 | 514.93 | 10,838,571,008.00 | 11183785 | 39.23% | 2007-02-06 09:30:00 | 46.40 | 8.38% | Increased |
| 2 | RVMD | Revolution Medicines, Inc. | 441565172 | 9455357 | 2025-11-14 | 76155X100 | 8 | 3.19 | 64.38 | 12,513,592,320.00 | 174277804 | 78.73% | 2020-02-13 09:30:00 | 26 | 0.97% | Increased |
| 3 | CELC | Celcuity Inc. | 391040125 | 7915792 | 2025-11-14 | 15102K100 | 9 | 2.83 | 86.00 | 3,648,697,344.00 | 20969939 | 66.06% | 2017-09-20 09:30:00 | 9.40 | 45.23% | Increased |
| 4 | ALKS | Alkermes plc | 242740530 | 8091351 | 2025-11-14 | G01767105 | 12 | 1.75 | 31.01 | 5,088,921,600.00 | 162459117 | 6.75% | 1991-07-16 09:30:00 | -26.20 | 26.22% | Increased |
| 5 | IMTX | Immatics N.V. | 103041681 | 12094094 | 2025-11-14 | N44445109 | 17 | 0.74 | 9.98 | 1,213,163,776.00 | 53889761 | 57.66% | 2018-12-12 09:30:00 | 30.80 | 18.93% | Increased |
| 6 | IDYA | IDEAYA Biosciences, Inc. | 89124831 | 3275444 | 2025-11-14 | 45166A102 | 19 | 0.64 | 31.82 | 2,551,092,480.00 | 81837469 | 30.79% | 2019-05-23 09:30:00 | 27.50 | 54.59% | Increased |
| 7 | ARWR | Arrowhead Pharmaceuticals, Inc. | 57624581 | 1670762 | 2025-11-14 | 04280A100 | 25 | 0.42 | 41.14 | 5,687,915,520.00 | 119533330 | 100.59% | 1993-12-16 09:30:00 | 12.60 | 77.90% | Increased |
| 8 | NTLA | Intellia Therapeutics, Inc. | 47435060 | 2746674 | 2025-11-14 | 45826J105 | 29 | 0.34 | 8.67 | 1,087,643,008.00 | 110407927 | -21.11% | 2016-05-06 09:30:00 | 18.40 | 2.65% | Increased |
| 9 | RAPP | Rapport Therapeutics, Inc. | 45948573 | 1547090 | 2025-11-14 | 75383L102 | 31 | 0.33 | 24.67 | 1,177,468,416.00 | 30650878 | 65.13% | 2024-06-07 09:30:00 | 85.80 | 181.24% | Increased |
| 10 | SYRE | Spyre Therapeutics, Inc. | 16760000 | 1000000 | 2025-11-14 | 00773J202 | 50 | 0.12 | 22.63 | 1,755,909,760.00 | 67593608 | 33.51% | 2016-04-07 09:30:00 | 37.70 | 59.57% | Increased |
| 11 | CTMX | CytomX Therapeutics, Inc. | 13560135 | 4250826 | 2025-11-14 | 23284F105 | 57 | 0.10 | 3.86 | 716,711,680.00 | 133365988 | 102.09% | 2015-10-08 09:30:00 | 26.40 | 22.00% | Increased |
| 12 | XNCR | Xencor, Inc. | 12927703 | 1102106 | 2025-11-14 | 98401F105 | 59 | 0.09 | 13.99 | 999,032,512.00 | 59914098 | 82.16% | 2013-12-03 09:30:00 | 44 | 64.39% | Increased |
| 13 | VTVT | vTv Therapeutics, Inc. | 3463132 | 148314 | 2025-11-14 | 918385204 | 75 | 0.03 | 31.27 | 123,141,824.00 | 1413906 | 102.53% | 2015-07-30 09:30:00 | 55 | 52.41% | Increased |
------------------------------------------------------------ ------------------------------------------------------------ Baker Closed Positions
| SYMBOL | NAME_OF_ISSUER | VALUE | SHARES | DATE | CUSIP | RANK | PERCENT | Price | Mkt. Cap | Float | 3 Month Percentage Change | First Traded | Months to 0$ | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | VRNA | Verona Pharma plc | 21171071 | 223843 | 2025-08-14 | 925050106 | 36 | 0.21 | NaN | NaN | NaN | NaN | NaN | NaN | Closed |
| 1 | VERV | Verve Therapeutics, Inc. | 18995882 | 1691530 | 2025-08-14 | 92539P101 | 39 | 0.18 | NaN | NaN | NaN | NaN | NaN | NaN | Closed |
| 2 | BPMC | Blueprint Medicines Corporation | 16091461 | 125538 | 2025-08-14 | 09627Y109 | 43 | 0.16 | NaN | NaN | NaN | NaN | NaN | NaN | Closed |
| 3 | IGMS | IGM Biosciences, Inc. | 4587755 | 4096210 | 2025-08-14 | 449585108 | 69 | 0.04 | NaN | NaN | NaN | NaN | NaN | NaN | Closed |
| 4 | FATE | Fate Therapeutics, Inc. | 2783220 | 2485018 | 2025-08-14 | 31189P102 | 72 | 0.03 | 0.99 | 114,441,656.00 | 100797002 | -8.96% | 2013-10-01 09:30:00 | 21.20 | Closed |
| 5 | CADL | Candel Therapeutics, Inc. | 1796867 | 355112 | 2025-08-14 | 137404109 | 77 | 0.02 | 4.61 | 253,066,416.00 | 45478394 | -24.30% | 2021-07-27 09:30:00 | 29.30 | Closed |
| 6 | RCKT | Rocket Pharmaceuticals, Inc. | 1352594 | 552079 | 2025-08-14 | 77313F106 | 80 | 0.01 | 3.17 | 345,769,984.00 | 78587735 | 4.62% | 2015-02-18 09:30:00 | 11.80 | Closed |
| 7 | HOOK | HOOKIPA Pharma Inc. | 1020082 | 812814 | 2025-08-14 | 43906K209 | 82 | 0.01 | NaN | NaN | NaN | NaN | NaN | NaN | Closed |
| 8 | NMRA | Neumora Therapeutics, Inc. | 758672 | 1034600 | 2025-08-14 | 640979100 | 83 | 0.01 | 2.69 | 449,469,728.00 | 84127410 | 70.25% | 2023-09-14 09:30:00 | 9.60 | Closed |
| 9 | Generation Bio Co. | 622577 | 1944945 | 2025-08-14 | 37148K100 | 84 | 0.01 | NaN | NaN | NaN | NaN | NaN | NaN | Closed |
------------------------------------------------------------ ------------------------------------------------------------ Baker Decreased Positions
| SYMBOL | NAME_OF_ISSUER | VALUE | SHARES | DATE | CUSIP | RANK | PERCENT | Price | Mkt. Cap | Float | 3 Month Percentage Change | First Traded | Months to 0$ | PCT_CHANGE | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | INSM | Insmed Incorporated | 965368731 | 6703484 | 2025-11-14 | 457669307 | 4 | 6.98 | 190.96 | 40,436,649,984.00 | 192368404 | 49.42% | 2000-06-01 09:30:00 | 22.50 | -13.09% | Decreased |
| 1 | GPCR | Structure Therapeutics Inc. | 43571052 | 1556109 | 2025-11-14 | 86366E106 | 32 | 0.31 | 35.00 | 2,179,540,736.00 | 133007309 | 73.96% | 2023-02-03 09:30:00 | 44 | -37.97% | Decreased |
| 2 | CERS | Cerus Corporation | 15913269 | 10008345 | 2025-11-14 | 157085101 | 51 | 0.11 | 1.60 | 316,944,384.00 | 173491510 | 29.03% | 1997-01-31 09:30:00 | -2,499.90 | -22.32% | Decreased |
| 3 | KALA | KALA BIO, Inc. | 1507192 | 985093 | 2025-11-14 | 483119202 | 83 | 0.01 | 0.66 | 4,619,844.00 | 5349050 | -92.09% | 2017-07-20 09:30:00 | 7.90 | -18.04% | Decreased |
| 4 | CTNM | Contineum Therapeutics, Inc. | 912623 | 77670 | 2025-11-14 | 21217B100 | 85 | 0.01 | 10.90 | 304,665,408.00 | 16443178 | 47.70% | 2024-04-05 09:30:00 | 29.20 | -75.15% | Decreased |
------------------------------------------------------------ ------------------------------------------------------------ Baker Unchanged Positions
| SYMBOL | NAME_OF_ISSUER | VALUE | SHARES | DATE | CUSIP | RANK | PERCENT | Price | Mkt. Cap | Float | 3 Month Percentage Change | First Traded | Months to 0$ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ONC | BeOne Medicines Ltd. | 2997837357 | 8799053 | 2025-11-14 | 07725L102 | 1 | 21.66 | 368.36 | NaN | None | 14.63% | None | None |
| 1 | ACAD | ACADIA Pharmaceuticals Inc. | 915415365 | 42896690 | 2025-11-14 | 004225108 | 5 | 6.61 | 23.64 | 4,012,992,768.00 | 116336185 | -6.67% | 2004-05-27 09:30:00 | -35.70 |
| 2 | SMMT | Summit Therapeutics Inc. | 696716643 | 33722974 | 2025-11-14 | 86627T108 | 6 | 5.03 | 18.26 | 14,077,408,256.00 | 102546960 | -30.96% | 2015-03-05 09:30:00 | 9.30 |
| 3 | RYTM | Rhythm Pharmaceuticals, Inc. | 565996738 | 5604483 | 2025-11-14 | 76243J105 | 7 | 4.09 | 95.89 | 6,452,041,728.00 | 55119978 | -0.61% | 2017-10-09 09:30:00 | 45.30 |
| 4 | KYMR | Kymera Therapeutics, Inc. | 376470881 | 6651429 | 2025-11-14 | 501575104 | 10 | 2.72 | 63.63 | 4,333,129,728.00 | 47266194 | 49.26% | 2020-08-21 09:30:00 | 28.60 |
| 5 | KOD | Kodiak Sciences Inc. | 283372721 | 17310490 | 2025-11-14 | 50015M109 | 11 | 2.05 | 18.87 | 996,745,280.00 | 29509383 | 78.52% | 2018-10-04 09:30:00 | 4.50 |
| 6 | ABCL | AbCellera Biologics Inc. | 138453969 | 27525640 | 2025-11-14 | 00288U106 | 13 | 1.00 | 3.62 | 1,200,333,568.00 | 202870377 | -21.13% | 2020-12-11 09:30:00 | 22.70 |
| 7 | EWTX | Edgewise Therapeutics, Inc. | 118502347 | 7305940 | 2025-11-14 | 28036F105 | 14 | 0.86 | 20.42 | 2,241,234,688.00 | 61055385 | 44.31% | 2021-03-26 09:30:00 | 46.90 |
| 8 | KNSA | Kiniksa Pharmaceuticals International, plc | 109681897 | 2824669 | 2025-11-14 | G52694109 | 15 | 0.79 | 40.29 | 2,805,200,896.00 | 34321078 | 20.70% | 2018-05-25 09:30:00 | -37 |
| 9 | STOK | Stoke Therapeutics, Inc. | 108895193 | 4633838 | 2025-11-14 | 86150R107 | 16 | 0.79 | 26.07 | 1,489,044,096.00 | 40560031 | 43.16% | 2019-06-19 09:30:00 | 22.90 |
| 10 | GRAL | GRAIL, Inc. | 96389291 | 1630125 | 2025-11-14 | 384747101 | 18 | 0.70 | 83.20 | 2,999,176,960.00 | 31063830 | 156.55% | 2024-06-12 09:30:00 | 18.80 |
| 11 | IMVT | Immunovant, Inc. | 87981042 | 5457881 | 2025-11-14 | 45258J102 | 20 | 0.64 | 22.82 | 4,108,481,792.00 | 67472699 | 49.93% | 2019-06-21 09:30:00 | 13.80 |
| 12 | IMCR | Immunocore Holdings plc | 84382092 | 2322656 | 2025-11-14 | 45258D105 | 21 | 0.61 | 35.37 | 1,783,218,560.00 | 37679523 | 7.57% | 2021-02-05 09:30:00 | Missing |
| 13 | BCYC | Bicycle Therapeutics plc | 84252663 | 10885357 | 2025-11-14 | 088786108 | 22 | 0.61 | 6.60 | 559,798,912.00 | None | -11.29% | 2019-05-23 09:30:00 | 25.40 |
| 14 | RARE | Ultragenyx Pharmaceutical Inc. | 83402575 | 2772692 | 2025-11-14 | 90400D108 | 23 | 0.60 | 32.90 | 3,170,253,056.00 | 92889576 | 13.41% | 2014-01-31 09:30:00 | 12.30 |
| 15 | ROIV | Roivant Sciences Ltd. | 57006405 | 3767773 | 2025-11-14 | G76279101 | 26 | 0.41 | 20.56 | 14,438,405,120.00 | 464539714 | 74.98% | 2020-12-08 09:30:00 | 66.40 |
| 16 | DNLI | Denali Therapeutics Inc. | 54184211 | 3731695 | 2025-11-14 | 24823R105 | 27 | 0.39 | 17.15 | 2,569,515,520.00 | 132495767 | 16.67% | 2017-12-08 09:30:00 | 22.50 |
| 17 | MRUS | Merus N.V. | 54077595 | 574377 | 2025-11-14 | N5749R100 | 28 | 0.39 | 96.08 | 7,217,370,112.00 | 65817926 | 42.87% | 2016-05-19 09:30:00 | 26.40 |
| 18 | REPL | Replimune Group, Inc. | 46279958 | 11045336 | 2025-11-14 | 76029N106 | 30 | 0.33 | 8.98 | 695,792,384.00 | 54280434 | 61.51% | 2018-07-20 09:30:00 | 10.30 |
| 19 | VRDN | Viridian Therapeutics, Inc. | 37644281 | 1744406 | 2025-11-14 | 92790C104 | 34 | 0.27 | 28.49 | 2,719,142,912.00 | 85150496 | 53.67% | 2014-06-18 09:30:00 | 15.90 |
| 20 | PRAX | Praxis Precision Medicines, Inc. | 36542864 | 689488 | 2025-11-14 | 74006W207 | 36 | 0.26 | 178.08 | 4,539,801,600.00 | 20662675 | 278.25% | 2020-10-16 09:30:00 | 10.80 |
| 21 | GLUE | Monte Rosa Therapeutics, Inc. | 36428264 | 4916095 | 2025-11-14 | 61225M102 | 37 | 0.26 | 14.32 | 922,067,456.00 | 24476464 | 212.66% | 2021-06-24 09:30:00 | -13.20 |
| 22 | BNTX | BioNTech SE | 36383186 | 368923 | 2025-11-14 | 09075V102 | 38 | 0.26 | 103.88 | 24,870,307,840.00 | 93871403 | -8.49% | 2019-10-10 09:30:00 | -365.30 |
| 23 | NRIX | Nurix Therapeutics, Inc. | 35870835 | 3882125 | 2025-11-14 | 67080M103 | 39 | 0.26 | 12.43 | 1,233,663,616.00 | 71435476 | 17.71% | 2020-07-24 09:30:00 | 18.90 |
| 24 | DNTH | Dianthus Therapeutics, Inc. | 31077017 | 789759 | 2025-11-14 | 252828108 | 40 | 0.22 | 35.50 | 1,660,159,360.00 | 25289560 | 71.17% | 2018-06-21 09:30:00 | 38 |
| 25 | TRDA | Entrada Therapeutics, Inc. | 28221750 | 4865819 | 2025-11-14 | 29384C108 | 41 | 0.20 | 8.78 | 335,564,832.00 | 19389268 | 66.60% | 2021-10-29 09:30:00 | 33.30 |
| 26 | ARGX | argenx SE | 27850266 | 37760 | 2025-11-14 | 04016X101 | 42 | 0.20 | 891.73 | 50,394,169,344.00 | 61146679 | 36.39% | 2017-05-18 09:30:00 | None |
| 27 | PCVX | Vaxcyte, Inc. | 23084678 | 640885 | 2025-11-14 | 92243G108 | 44 | 0.17 | 45.55 | 5,968,016,384.00 | 117926907 | 39.30% | 2020-06-12 09:30:00 | 31.50 |
| 28 | IRON | Disc Medicine, Inc. | 22272264 | 337050 | 2025-11-14 | 254604101 | 45 | 0.16 | 87.04 | 3,155,158,528.00 | 32136713 | 45.41% | 2020-08-12 09:30:00 | 37.10 |
| 29 | CDTX | Cidara Therapeutics, Inc. | 21763567 | 227272 | 2025-11-14 | 171757206 | 46 | 0.16 | 105.99 | 3,367,785,728.00 | 27705631 | 62.52% | 2015-04-15 09:30:00 | 29.50 |
| 30 | CLDX | Celldex Therapeutics, Inc. | 17213122 | 665370 | 2025-11-14 | 15117B202 | 47 | 0.12 | 23.72 | 1,611,399,680.00 | 53249948 | -6.98% | 1986-05-15 09:30:00 | 34.10 |
| 31 | NGNE | Neurogene Inc. | 17186005 | 991691 | 2025-11-14 | 64135M105 | 48 | 0.12 | 26.49 | 378,063,040.00 | 4799645 | 31.14% | 2014-03-07 09:30:00 | 37.40 |
| 32 | SERA | Sera Prognostics, Inc. | 16824400 | 5498170 | 2025-11-14 | 81749D107 | 49 | 0.12 | 2.95 | 112,282,512.00 | 24429249 | 31.11% | 2021-07-15 09:30:00 | 16.40 |
| 33 | AKRO | Akero Therapeutics, Inc. | 15413432 | 324630 | 2025-11-14 | 00973Y108 | 52 | 0.11 | 54.20 | 4,469,768,192.00 | 65582946 | 9.76% | 2019-06-20 09:30:00 | 31.40 |
| 34 | XENE | Xenon Pharmaceuticals Inc. | 14863851 | 370208 | 2025-11-14 | 98420N105 | 53 | 0.11 | 40.04 | 3,094,091,264.00 | 71764524 | 4.73% | 2014-11-05 09:30:00 | 17.80 |
| 35 | DBVT | DBV Technologies S.A. | 14614250 | 1461425 | 2025-11-14 | 23306J309 | 54 | 0.11 | 13.06 | 498,870,432.00 | 65195957 | 30.73% | 2014-10-22 09:30:00 | 5 |
| 36 | PRLD | Prelude Therapeutics Inc. | 14578307 | 10123824 | 2025-11-14 | 74065P101 | 55 | 0.11 | 1.51 | 85,466,520.00 | 15769332 | 73.56% | 2020-09-25 09:30:00 | 3.90 |
| 37 | ACLX | Arcellx, Inc. | 13696333 | 166825 | 2025-11-14 | 03940C100 | 56 | 0.10 | 87.42 | 5,217,357,824.00 | 39702918 | 18.01% | 2022-02-04 09:30:00 | 26.50 |
| 38 | TSHA | Taysha Gene Therapies, Inc. | 13095552 | 4004756 | 2025-11-14 | 877619106 | 58 | 0.09 | 4.01 | 1,098,416,640.00 | 174549642 | 36.39% | 2020-09-24 09:30:00 | 35.20 |
| 39 | DSGN | Design Therapeutics, Inc. | 12898001 | 1712882 | 2025-11-14 | 25056L103 | 60 | 0.09 | 7.06 | 433,494,176.00 | 23350583 | 32.46% | 2021-03-29 09:30:00 | 53.80 |
| 40 | NUVL | Nuvalent, Inc. | 12447672 | 143937 | 2025-11-14 | 670703107 | 61 | 0.09 | 94.68 | 7,221,230,592.00 | 41265461 | 23.28% | 2021-07-29 09:30:00 | 35.20 |
| 41 | SION | Sionna Therapeutics, Inc. | 11764000 | 400000 | 2025-11-14 | 829401108 | 62 | 0.09 | 35.88 | NaN | None | 71.59% | None | None |
| 42 | CRNX | Crinetics Pharmaceuticals, Inc. | 11662000 | 280000 | 2025-11-14 | 22663K107 | 63 | 0.08 | 41.43 | 4,063,268,608.00 | 87881231 | 34.86% | 2018-07-18 09:30:00 | 27.80 |
| 43 | AGIO | Agios Pharmaceuticals, Inc. | 7621221 | 189866 | 2025-11-14 | 00847X104 | 66 | 0.06 | 42.54 | 2,521,489,408.00 | 51540663 | 14.94% | 2013-07-24 09:30:00 | 27.80 |
| 44 | SANA | Sana Biotechnology, Inc. | 7209869 | 2030949 | 2025-11-14 | 799566104 | 67 | 0.05 | 3.66 | 1,024,177,728.00 | 176978977 | 6.71% | 2021-02-04 09:30:00 | 14.10 |
| 45 | SGMT | Sagimet Biosciences Inc. | 6537553 | 952996 | 2025-11-14 | 786700104 | 68 | 0.05 | 7.74 | 251,717,184.00 | 22626577 | -10.73% | 2023-07-14 09:30:00 | 36.70 |
| 46 | ALMS | Alumis Inc. | 6234375 | 1562500 | 2025-11-14 | 022307102 | 69 | 0.05 | 5.28 | 549,459,520.00 | 71049902 | 11.16% | 2024-06-28 09:30:00 | 14.90 |
| 47 | RLAY | Relay Therapeutics, Inc. | 6055811 | 1160117 | 2025-11-14 | 75943R102 | 70 | 0.04 | 6.45 | 1,123,129,088.00 | 103390269 | 90.27% | 2020-07-16 09:30:00 | 27.30 |
| 48 | SKYE | Skye Bioscience, Inc. | 5701007 | 1450638 | 2025-11-14 | 83086J200 | 71 | 0.04 | 1.37 | 43,918,720.00 | 19262367 | -58.10% | 2015-01-06 09:30:00 | 9.10 |
| 49 | TCRX | TScan Therapeutics, Inc. | 5068321 | 2784792 | 2025-11-14 | 89854M101 | 73 | 0.04 | 1.13 | 64,125,232.00 | 44031335 | -37.22% | 2021-07-16 09:30:00 | 14.40 |
| 50 | VIR | Vir Biotechnology, Inc. | 3097898 | 542539 | 2025-11-14 | 92764N102 | 78 | 0.02 | 5.47 | 761,013,824.00 | 96865804 | 21.02% | 2019-10-11 09:30:00 | 7.60 |
| 51 | WVE | Wave Life Sciences Ltd. | 2518541 | 344063 | 2025-11-14 | Y95308105 | 79 | 0.02 | 6.67 | 1,115,102,592.00 | 81853873 | -31.66% | 2015-11-11 09:30:00 | 11.60 |
| 52 | ELVN | Enliven Therapeutics, Inc. | 2350632 | 114833 | 2025-11-14 | 29337E102 | 80 | 0.02 | 20.27 | 1,200,704,640.00 | 36383658 | 0.25% | 2020-03-12 09:30:00 | 80.90 |
| 53 | TARA | Protara Therapeutics, Inc. | 2335219 | 536832 | 2025-11-14 | 74365U107 | 81 | 0.02 | 5.27 | 203,354,864.00 | 35480986 | 73.93% | 2014-10-22 09:30:00 | 30.40 |
| 54 | TECX | Tectonic Therapeutic, Inc. | 1569000 | 100000 | 2025-11-14 | 878972108 | 82 | 0.01 | 17.58 | 329,032,192.00 | 9745941 | -25.22% | 2018-06-21 09:30:00 | 43.20 |
| 55 | ALGS | Aligos Therapeutics, Inc. | 813939 | 83055 | 2025-11-14 | 01626L204 | 86 | 0.01 | 6.07 | 37,352,244.00 | 3003071 | -21.17% | 2020-10-16 09:30:00 | 10.60 |
| 56 | TYRA | Tyra Biosciences, Inc. | 148392 | 10607 | 2025-11-14 | 90240B106 | 88 | 0.00 | 15.59 | 832,070,976.00 | 17293093 | 45.29% | 2021-09-15 09:30:00 | 35.20 |
| 57 | ACRV | Acrivon Therapeutics, Inc. | 41284 | 22809 | 2025-11-14 | 004890109 | 89 | 0.00 | 2.07 | 65,113,180.00 | 16683130 | 53.33% | 2022-11-15 09:30:00 | 19.50 |
| 58 | SRZNW | Surrozen, Inc. | 14833 | 833333 | 2025-11-14 | 86889P117 | 90 | 0.00 | NaN | NaN | NaN | NaN | NaN | NaN |
| 59 | OPT | Opthea Limited | 0 | 2087320 | 2025-11-14 | 68386J208 | 91 | 0.00 | NaN | 583,100,736.00 | 784078044 | nan% | 2020-10-16 09:30:00 | Missing |
------------------------------------------------------------ ------------------------------------------------------------ Baker 13F positions: New: $ABVX, $GBIO, $HRTX, $IONS, $LBRX, $MBX, $PHVS, $RNA, $VKTX, $VTYX, $VYNE Increased: $ALKS, $ARWR, $CELC, $CTMX, $IDYA, $IMTX, $INCY, $MDGL, $NTLA, $RAPP, $RVMD, $SYRE, $VTVT, $XNCR Closed: $BPMC, $CADL, $FATE, $HOOK, $IGMS, $NMRA, $RCKT, $VERV, $VRNA Decreased: $CERS, $CTNM, $GPCR, $INSM, $KALA Unchanged: $ABCL, $ACAD, $ACLX, $ACRV, $AGIO, $AKRO, $ALGS, $ALMS, $ARGX, $BCYC, $BNTX, $CDTX, $CLDX, $CRNX, $DBVT, $DNLI, $DNTH, $DSGN, $ELVN, $EWTX, $GLUE, $GRAL, $IMCR, $IMVT, $IRON, $KNSA, $KOD, $KYMR, $MRUS, $NGNE, $NRIX, $NUVL, $ONC, $OPT, $PCVX, $PRAX, $PRLD, $RARE, $REPL, $RLAY, $ROIV, $RYTM, $SANA, $SERA, $SGMT, $SION, $SKYE, $SMMT, $SRZNW, $STOK, $TARA, $TCRX, $TECX, $TRDA, $TSHA, $TYRA, $VIR, $VRDN, $WVE, $XENE
End of Report - 2025-11-14 16:47:02
🎯
What FinRadar Offers
Deep analytics tools for smart investing
- ✓ Deep analytics tools looking at the market from different perspectives, in order to find the most interesting markets
- ✓ Macro economy dashboard with bullish and bearish ETF signals
- ✓ ETF analytics and interactive charts
- ✓ ETF pairs dashboard looking for divergences and opportunities
- ✓ Charting of factors, sectors, countries, and ratios
- ✓ ETF and stock signals from advanced technical analysis
- ✓ Hedge fund individual data and insights
- ✓ Complete aggregation of all hedge fund data in a stock screener, with current quarter and most recent complete quarter data and filters